Cite
MLA Citation
Martin Reck et al.. “Anti-angiogenic agents for NSCLC following first-line immunotherapy: Rationale, recent updates, and future perspectives.” Lung cancer, vol. 179, 2023, p. . http://access.bl.uk/ark:/81055/vdc_100184747330.0x000047